Cleared Traditional

K122632 - GUAVA II

K122632 is an FDA 510(k) clearance for GUAVA II, manufactured by Cardiocomm Solutions, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 531-day FDA review.

K122632 · Cardiocomm Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
531d
Days
Class 2
Risk

K122632 is an FDA 510(k) clearance for the GUAVA II. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Cardiocomm Solutions, Inc. (Apollo Beach, US). The FDA issued a Cleared decision on February 11, 2014 after a review of 531 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Cardiocomm Solutions, Inc. devices

FDA 510(k) Submission Details - K122632

510(k) Number K122632 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2012
Decision Date February 11, 2014
Days to Decision 531 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
406d slower than avg
Panel avg: 125d · This submission: 531d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 405
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K122632.
DIGITAL ELECTROCARDIOGRAPH
K131858 · Guangdong Biolight Meditech Co., Ltd. · Jun 2014
CONTEC ELECTROCARDIOGRAPH
K131900 · Contec Medical System Co., Ltd. · Mar 2014
SE-601 SERIES ELECTROCARDIOGRAPH
K131503 · Edan Instruments, Inc. · Feb 2014
ALIVECOR HEART MONITOR OTC
K130921 · AliveCor, Inc. · Feb 2014
DIGITAL ELECTROCARDIOGRAPH
K132758 · Shenzhen Biocare Bio-Medical Equipment Co., Ltd. · Jan 2014
MAC 2000 ECG ANALYSIS SYSTEM
K133622 · Wipro GE Healthcare · Jan 2014